ValiRx plc (LON:VAL – Get Free Report) traded down 9.5% during trading on Thursday . The stock traded as low as GBX 0.40 ($0.01) and last traded at GBX 0.43 ($0.01). 1,353,628 shares changed hands during mid-day trading, a decline of 82% from the average session volume of 7,439,741 shares. The stock had previously closed at GBX 0.48 ($0.01).
ValiRx Trading Down 9.5 %
The company has a quick ratio of 1.27, a current ratio of 6.65 and a debt-to-equity ratio of 0.44. The company has a market cap of £1.63 million, a P/E ratio of -0.29 and a beta of 0.59. The business has a 50-day moving average price of GBX 0.65 and a two-hundred day moving average price of GBX 1.06.
ValiRx Company Profile
ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.
Recommended Stories
- Five stocks we like better than ValiRx
- What Do S&P 500 Stocks Tell Investors About the Market?
- Homebuilders in Freefall: Bargain Opportunity or Falling Knife?
- Most active stocks: Dollar volume vs share volume
- The 3 Most Talked About Investments on WallStreetBets Right Now
- Best Stocks Under $10.00
- Analyst Targets Signal More Growth in CrowdStrike Stock
Receive News & Ratings for ValiRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ValiRx and related companies with MarketBeat.com's FREE daily email newsletter.
